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Résumé en
anglais
Objective Interleukin-26 (IL-26) is a member of the IL-10 cytokine family, first
discovered based on its peculiar expression by virus-transformed T cells. IL-26 is
overexpressed in chronic inflammation (rheumatoid arthritis and Crohn’s disease)
and induces proinflammatory cytokines by myeloid cells and some epithelial cells. We
thus investigated the expression and potential role of IL-26 in chronic HCV infection,
a pathology associated with chronic inflammation.Design IL-26 was quantified in a
cohort of chronically HCV-infected patients, naive of treatment and its expression in
the liver biopsies investigated by immunohistochemistry. We also analysed the ability
of IL-26 to modulate the activity of natural killer (NK) cells, which control HCV
infection. Results The serum levels of IL-26 are enhanced in chronically HCV-infected
patients, mainly in those with severe liver inflammation. Immunohistochemistry
reveals an intense IL-26 staining in liver lesions, mainly in infiltrating CD3+ cells. We
also show that NK cells from healthy subjects and from HCV-infected patients are
sensitive to IL-26. IL-26 upregulates membrane tumour necrosis factor (TNF)-related
apoptosis-inducing ligand (TRAIL) expression on CD16− CD56bright NK cells,
enabling them to kill HCV-infected hepatoma cells, with the same efficacy as
interferon (IFN)-α-treated NK cells. IL-26 also induces the expression of the antiviral
cytokines IFN-β and IFN-γ, and of the proinflammatory cytokines IL-1β and TNF-α by
NK cells. Conclusions This study highlights IL-26 as a new player in the inflammatory
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